Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Syrian refugee children have been making clothes for British shoppers, it has been claimed.
A judgement is due on Monday on a Christian bakery’s appeal against a ruling that found them guilty of discrimination against a gay man.
The crash happened at about 7.20am local time as the plane was heading for Misrata in Libya.